Glaxosmithkline Share News (GSK)

Fri, 13th Jul 2012 07:17

July 13 (Reuters) - :

* Jefferies cuts Abbott Laboratories price target to $75 from $76;

rating buy

* Jefferies cuts Bayer price target to eur 56 from eur 57; rating

hold

* Jefferies raises Bristol-Myers Squibb price target to $39 from

$38; rating buy

* Jefferies cuts Glaxosmithkline price target to 1600p from 1650p;

rating buy

* Jefferies raises J&J price target to $75 from $72; rating buy

* Jefferies raises Eli Lilly price target to $37 from $36; rating hold

* Jefferies raises Merck price target to $42 from $40; rating hold

* Jefferies cuts Merck KGaA price target to eur 78 from eur 81;

rating hold

* Jefferies raises Novartis price target to Sfr 60 from Sfr 56;

rating buy

* Jefferies raises Novo Nordisk A/S price target to Dkk 1,050 from

Dkk 1000; rating buy

* Jefferies cuts Pfizer price target to $25 from $26; rating buy

* Jefferies cuts Roche price target to Sfr 190 from Sfr 200; rating

buy



For a summary of rating actions and price target changes on European companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1580



For a summary of rating and price target changes on U.S. companies:

Reuters Eikon users, click on

Reuters 3000Xtra users, double-click

Reuters Station users, click .1568



(Bangalore Equities Newsdesk +91 80 4135 5800; within U.S. +1 646 223 8780)

COPYRIGHT
Copyright Thomson Reuters 2012. All rights reserved.
The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.